Table 1.
Past | Present | Future | |
---|---|---|---|
Study methodology | Small physiological, observational, and single-centre comparative trials; poorly defined and underdeveloped processes | Large phase III trials (usually in the 1000s); a priori defined protocols, outcomes, and interim analyses |
Sophisticated statistical techniques; larger sample sizes (tens of thousands); adaptive trial designs |
Population | Small, specific populations often from specialist centres | General, heterogenic populations | Homogenous; selected based on anticipated response to nutrition intervention (e.g., malnourished); includes non-invasively ventilated cohorts |
Intervention | Calories; early vs. late initiation; route of delivery e.g., gastric vs. jejunal, EN vs. PN, protein- vs. glucose-based PN, medium- vs. long-chain triglycerides and branched chain amino acids; immunonutrition | General interventions for general questions; focused only on the period in ICU |
Synergistic; patient-specific; based on mechanisms; extension of interventions beyond ICU discharge considering illness trajectory |
Outcomes | Calorie delivery; nitrogen balance; incidence of infection; mortality (but underpowered to show an effect in the latter) | Robust clinical outcomes such as mortality | Patient recovery; functional outcomes; valid surrogate markers |
Abbreviations: EN = enteral nutrition; ICU = intensive care unit; PN = parenteral nutrition.